Hematopoietic Cell Transplantation Panel - Disclosures
Panel Member
|
Marian Birkeland PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Nicole Blankenhorn |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Javier Bolaños-Meade MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Jonathan Brammer MD |
Grant/Research Support
|
| Celgene Corporation | Incyte Corporation |
Date Completed
|
10/07/2024 |
Panel Member
|
Meredith Cowden MA |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Sarah DeVincenzo PharmD, BCPS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Mary Dwyer MS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Areej El-Jawahri MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Meghan Fay BSN, RN, OCN |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kristina Gregory MSN, RN |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Krishna Gundabolu MBBS, MS, FACP |
Equity Interest/Stock Options
|
| Geron |
Date Completed
|
10/14/2024 |
Panel Member
|
Jonathan Gutman MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Erin Hesler |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Vincent Ho MD |
Grant/Research Support
|
| CareDx | Jazz Pharmaceuticals Inc. |
Date Completed
|
01/16/2025 |
Panel Member
|
Rasmus Hoeg MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Mitchell Horwitz MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Omer Jamy MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Frankie Jones |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Adetola Kassim MD, MS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Mohamed Kharfan Dabaja MD |
Grant/Research Support
|
| Bristol Myers Squibb | Novartis Pharmaceuticals Corporation | Pharmacyclics |
Date Completed
|
07/30/2024 |
Panel Member
|
Lauren Lee MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Aaron Logan MD, PhD, MPhil |
Grant/Research Support
|
| Amgen Inc. | Autolus | Kite Pharma | sanofi-aventis U.S. |
Date Completed
|
05/12/2025 |
Panel Member
|
Alison Loren MD, MSCE |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
John Magenau MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Marco Mielcarek MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Varun Mittal MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Jonathan Moreira MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Lori Muffly MD |
Grant/Research Support
|
| Jasper | Kite Pharma |
Date Completed
|
09/27/2024 |
Panel Member
|
Ryotaro Nakamura MD |
Grant/Research Support
|
| Helocyte | Miyarisan |
Date Completed
|
08/14/2024 |
Panel Member
|
Mariam Nawas MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Yago Nieto MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Cameron Ninos PharmD |
Equity Interest/Stock Options
|
| Eli Lilly and Company |
Date Completed
|
04/04/2025 |
Panel Member
|
Caspian Oliai MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Genovefa Papanicolaou MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Joseph Pidala MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Brion Randolph MD |
Product/Speakers Bureau
|
| Bristol Myers Squibb |
Date Completed
|
11/13/2024 |
Panel Member
|
Tim Rinehart |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Mark Schroeder MD, MSCI |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Katie Stehman MMS, PA-C |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Jeffrey Tessier MD, FACP, FIDSA |
Grant/Research Support
|
| Ansun |
Date Completed
|
08/19/2024 |
Panel Member
|
Jeffrey Topal MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Dimitrios Tzachanis MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Asya Varshavsky-Yanovsky MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |